Genelux Corp (GNLX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.44-3.17%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · GNLX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenues | — | 0.0 | 0.0 | 0.2 | 11.1 | — |
| Operating Expenses & Income | ||||||
| R&D Expenses | 22.7 | 19.9 | 19.0 | 12.8 | 9.1 | — |
| Operating Income | (36.4) | (33.2) | (31.7) | (24.2) | (3.0) | — |
| Earnings from Continuing Operations | ||||||
| Interest & Investment Income | 0.6 | 0.7 | 0.7 | 0.2 | — | — |
| Other Non-Operating Income / Expenses | 0.8 | 1.1 | 1.8 | (4.1) | (1.1) | — |
| Income Tax Expense | — | — | — | — | 1.1 | — |
| Net Income | ||||||
| Net Income | (35.6) | (32.1) | (29.9) | (28.3) | (5.2) | — |
| Per Share | ||||||
| Basic EPS | (0.79) | (0.86) | (0.95) | (1.16) | (0.57) | — |
| Diluted EPS | (0.79) | (0.86) | (0.95) | (1.16) | (0.57) | — |
| Basic Weighted Avg Shares | 45.0 | 37.2 | 31.5 | 31.5 | 9.1 | — |
| Diluted Weighted Avg Shares | 45.0 | 37.2 | 31.5 | 24.4 | 9.1 | — |
| Supplemental | ||||||
| EBIT | (36.4) | (33.2) | (31.7) | (24.2) | (3.0) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.